# DESCRIPTION

## FIELD OF THE INVENTION

## BACKGROUND OF THE INVENTION

## SUMMARY OF THE INVENTION

## DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

### Definitions

### Oral

### Nasal

### Transmucosal or Transdermal

### Parenteral

### Salts, Esters, Hydrates and Solvates

### Stereoisomers, Enantiomers, Racemates, Tautomers

### Dosages

### Toxicity and Therapeutic Efficacy

## EXAMPLE 1

### guaA Expression in S. aureus Isolates from Infected Cows and from Milk

## EXAMPLE 2

### Polycistronic RNA Encoding xpt/pbuX/guaB/guaA

## EXAMPLE 3

### Ability of Compounds of the Invention to Bind Guanine Riboswitches

## EXAMPLE 4

### Growth Inhibition of Bacterial Species Possessing a Guanine Riboswitch that Controls the Expression of the guaA Gene by Compounds of the Present Invention

### EXAMPLE 5

### EXAMPLE 6

### EXAMPLE 7

### EXAMPLE 8

### EXAMPLE 9

### EXAMPLE 10

### EXAMPLE 11

### EXAMPLE 12

### EXAMPLE 13

### EXAMPLE 14

### EXAMPLE 15

### EXAMPLE 16

